
Blog
August 17, 2025 | Source: Sayer Ji’s Substack | by Sayer Ji
The FDA has moved Armour, NP, and all natural thyroid medicines into the “unapproved drug” category. That doesn’t mean unsafe — many patients have relied on them for decades — but it does create stigma and uncertainty around access.
Dr. Marty Makary has emphasized the FDA’s commitment to pursue the first-ever approval of DTE pending trial results. That’s encouraging, but until approval is achieved, every current DTE remains in a vulnerable position.
Patients deserve clarity and continuity, not doubt. This step is best seen as a transition moment — one that requires vigilance and advocacy to ensure access is truly protected.]
The post The FDA’s War on Natural Thyroid: A Medical Tyranny That Threatens Millions appeared first on Organic Consumers.